Tag: #AntimicrobialStewardship

Are You Antibiotics Aware? U.S. Antibiotic Awareness Week is November 18-24, 2022

U.S. Antibiotic Awareness Week is an annual observance that raises awareness of the threat of antibiotic resistance and the importance of appropriate antibiotic use. The observance is a partnership between the CDC, state-based programs (such as the Nebraska Department of Health and Human Services, Healthcare-Associated Infections/Antibiotic Resistance Team), and non-profit/for-profit partners.

Nov 15, 2022

In Case You Missed It: Last Call for Antimicrobial Stewardship Summit Registrations

Today is the final day to register for the Nebraska Antimicrobial Stewardship Summit on Friday, August 12, at the Embassy Suites by Hilton in Downtown Omaha.

Aug 4, 2022

Nebraska ASAP to Host Upcoming Antimicrobial Stewardship Summit

This summit is designed to highlight the importance of antimicrobial stewardship and focus on implementation strategies to promote facility-wide incorporation and improved antimicrobial use and patient outcomes.

Jul 31, 2022

#PharmToExamTable: Cefazolin vs Oxacillin for MSSA IE

A #PharmToExamTable question about Infective Endocarditis treatment, answered by Amanda Vanderwerf, PharmD, a 2021 Graduate of UNMC College of Pharmacy who is now an Emergency Medicine Pharmacy Resident at UNMC.

Jun 8, 2022

Antibiotic Awareness Week Publication Alert: Confronting antimicrobial resistance beyond the COVID-19 pandemic

Antibiotic Awareness Week 2021,”an annual observance that raises awareness of the threat of antibiotic resistance and the importance of appropriate antibiotic use” runs this year from November 18-24 2021. This is a global campaign with messaging from the CDC and the WHO calling on all of us to not only Be Antibiotics Aware, but to actively engage in activities to reduce the spread of antimicrobial resistance. To kick off #USAAW21 and #WAAW21, we share this #ThrowbackThursday publication from September 2020: Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election.

Nov 18, 2021

UNMC ID Antimicrobial Stewardship Pharmacists celebrated with Acute Care Pharmacist of the Year and Rising Star Pharmacist Awards

Thirty-three acute care pharmacists received heartfelt nominations from sixty-five peers and colleagues for Pharmacist of the Year 2021. This year, two awards were given – the Acute Care Pharmacist of the Year Award, and the Rising Star Pharmacist Award: both awardees came from the UNMC ID division.

Nov 15, 2021

We appreciate our ID Pharmacists

We LOVE our UNMC ID Pharmacists! Today marks the end of National Pharmacy Week and we want to share our appreciation and thanks for the hard work and invaluable contributions of our pharmacists at UNMC ID. Our pharmacists are exceptional clinicians giving us the clinical advice we need on antimicrobials and drug interactions. They are […]

Oct 22, 2021

Welcoming our new Infectious Diseases Pharmacy Resident: Jeremy Tigh PharmD

We are excited to welcome Jeremy Tigh PharmD as a new PGY-2 in our ID Pharmacy Residency Program! He’s the third ID Pharmacy resident we have had and a fantastic addition to our team! Read on to learn a little more about him…

Oct 5, 2021

Jeremy wearing a mask with his daughter on his shoulders laughing underneath a tree

#PharmToExamTable: What is the evidence for continuous infusion dosing of cefazolin?

The following is a clinical review written by Corey Paz, PharmD. Recent graduate of UNMC College of Pharmacy and new PGY1 Pharmacy Resident at Gunderson Health System in LaCrosse, Wisconsin. Follow him on Twitter @coreypaz. Corey was supervised by Scott Bergman, PharmD, FCCP, FIDSA, BCPS. Pharmacy Coordinator for Antimicrobial Stewardship at Nebraska Medicine and Clinical […]

Mar 30, 2020

Should We Add Daptomycin to β-Lactams in the Initial Treatment of Methicillin-susceptible S. aureus Bacteremia?

Content from Dr. Razan El Ramahi, originally posted in IDSA journal club.  Despite the availability of active antibiotics to treat Staphylococcus aureus bacteremia (SAB), controversy still exists regarding the optimal antibiotic strategy and whether combination antibiotics improve outcomes. In small clinical studies, a possible benefit was observed by adding daptomycin to β-lactams in the treatment of SAB. However, […]

Jan 28, 2020